Global Transarterial Chemoembolization (TACE) Market Research Report 2024(Status and Outlook)
Report Overview
Trans-arterial Chemoembolization (TACE) is an interventional radiology procedure that delivers anti-cancer medication (chemotherapy) and embolizing materials directly into blood vessels feeding a malignant liver tumor. TACE is a two-pronged approach that can simultaneously limit the blood supply feeding a tumor in order to destroy cancerous cells (embolization) while the chemotherapy prevents further growth.Transarterial Chemoembolization (TACE) is a minimally invasive procedure in which chemotherapy and embolic agents are directly delivered to a cancerous tumour via its blood supply. The embolic agents are used to cut off the blood supply to the tumour without affecting the rest of the liver. Compared to receiving conventional chemotherapy, TACE allows for the maximum amount of chemotherapy agent to reach the tumour, while limiting the amount released into the bloodstream.
The global Transarterial Chemoembolization (TACE) market size was estimated at USD 10930 million in 2023 and is projected to reach USD 19099.38 million by 2030, exhibiting a CAGR of 8.30% during the forecast period.
North America Transarterial Chemoembolization (TACE) market size was USD 2848.05 million in 2023, at a CAGR of 7.11% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Transarterial Chemoembolization (TACE) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transarterial Chemoembolization (TACE) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transarterial Chemoembolization (TACE) market in any manner.
Global Transarterial Chemoembolization (TACE) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Questex
Siemens Healthcare GmbH
Bellicum Pharmaceuticals Inc.
Boston Scientific
Cook Group
Hikma Pharmaceuticals
Nippon Kayaku
Novartis AG
Pfizer Inc.
Spectrum Pharmaceutical
Roche Holding AG
Celgene
Bayer AG
Merck & Co.
Inc.
SingHealth
Market Segmentation (by Type)
Chemotherapeutic Agents
Radio Therapeutic Agents
Drug-eluting Particles
Others
Market Segmentation (by Application)
Hospitals
Clinics
Cancer Research Centers
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Transarterial Chemoembolization (TACE) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
Trans-arterial Chemoembolization (TACE) is an interventional radiology procedure that delivers anti-cancer medication (chemotherapy) and embolizing materials directly into blood vessels feeding a malignant liver tumor. TACE is a two-pronged approach that can simultaneously limit the blood supply feeding a tumor in order to destroy cancerous cells (embolization) while the chemotherapy prevents further growth.Transarterial Chemoembolization (TACE) is a minimally invasive procedure in which chemotherapy and embolic agents are directly delivered to a cancerous tumour via its blood supply. The embolic agents are used to cut off the blood supply to the tumour without affecting the rest of the liver. Compared to receiving conventional chemotherapy, TACE allows for the maximum amount of chemotherapy agent to reach the tumour, while limiting the amount released into the bloodstream.
The global Transarterial Chemoembolization (TACE) market size was estimated at USD 10930 million in 2023 and is projected to reach USD 19099.38 million by 2030, exhibiting a CAGR of 8.30% during the forecast period.
North America Transarterial Chemoembolization (TACE) market size was USD 2848.05 million in 2023, at a CAGR of 7.11% during the forecast period of 2024 through 2030.
This report provides a deep insight into the global Transarterial Chemoembolization (TACE) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transarterial Chemoembolization (TACE) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transarterial Chemoembolization (TACE) market in any manner.
Global Transarterial Chemoembolization (TACE) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Questex
Siemens Healthcare GmbH
Bellicum Pharmaceuticals Inc.
Boston Scientific
Cook Group
Hikma Pharmaceuticals
Nippon Kayaku
Novartis AG
Pfizer Inc.
Spectrum Pharmaceutical
Roche Holding AG
Celgene
Bayer AG
Merck & Co.
Inc.
SingHealth
Market Segmentation (by Type)
Chemotherapeutic Agents
Radio Therapeutic Agents
Drug-eluting Particles
Others
Market Segmentation (by Application)
Hospitals
Clinics
Cancer Research Centers
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Transarterial Chemoembolization (TACE) Market
- Overview of the regional outlook of the Transarterial Chemoembolization (TACE) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Transarterial Chemoembolization (TACE) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Transarterial Chemoembolization (TACE)
1.2 Key Market Segments
1.2.1 Transarterial Chemoembolization (TACE) Segment by Type
1.2.2 Transarterial Chemoembolization (TACE) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Transarterial Chemoembolization (TACE) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Transarterial Chemoembolization (TACE) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Transarterial Chemoembolization (TACE) Sales by Manufacturers (2019-2024)
3.2 Global Transarterial Chemoembolization (TACE) Revenue Market Share by Manufacturers (2019-2024)
3.3 Transarterial Chemoembolization (TACE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transarterial Chemoembolization (TACE) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Transarterial Chemoembolization (TACE) Sales Sites, Area Served, Product Type
3.6 Transarterial Chemoembolization (TACE) Market Competitive Situation and Trends
3.6.1 Transarterial Chemoembolization (TACE) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transarterial Chemoembolization (TACE) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) INDUSTRY CHAIN ANALYSIS
4.1 Transarterial Chemoembolization (TACE) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transarterial Chemoembolization (TACE) Sales Market Share by Type (2019-2024)
6.3 Global Transarterial Chemoembolization (TACE) Market Size Market Share by Type (2019-2024)
6.4 Global Transarterial Chemoembolization (TACE) Price by Type (2019-2024)
7 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transarterial Chemoembolization (TACE) Market Sales by Application (2019-2024)
7.3 Global Transarterial Chemoembolization (TACE) Market Size (M USD) by Application (2019-2024)
7.4 Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
8 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY REGION
8.1 Global Transarterial Chemoembolization (TACE) Sales by Region
8.1.1 Global Transarterial Chemoembolization (TACE) Sales by Region
8.1.2 Global Transarterial Chemoembolization (TACE) Sales Market Share by Region
8.2 North America
8.2.1 North America Transarterial Chemoembolization (TACE) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transarterial Chemoembolization (TACE) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transarterial Chemoembolization (TACE) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transarterial Chemoembolization (TACE) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transarterial Chemoembolization (TACE) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Questex
9.1.1 Questex Transarterial Chemoembolization (TACE) Basic Information
9.1.2 Questex Transarterial Chemoembolization (TACE) Product Overview
9.1.3 Questex Transarterial Chemoembolization (TACE) Product Market Performance
9.1.4 Questex Business Overview
9.1.5 Questex Transarterial Chemoembolization (TACE) SWOT Analysis
9.1.6 Questex Recent Developments
9.2 Siemens Healthcare GmbH
9.2.1 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Basic Information
9.2.2 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Overview
9.2.3 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Market Performance
9.2.4 Siemens Healthcare GmbH Business Overview
9.2.5 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) SWOT Analysis
9.2.6 Siemens Healthcare GmbH Recent Developments
9.3 Bellicum Pharmaceuticals Inc.
9.3.1 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Basic Information
9.3.2 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Overview
9.3.3 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.3.4 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) SWOT Analysis
9.3.5 Bellicum Pharmaceuticals Inc. Business Overview
9.3.6 Bellicum Pharmaceuticals Inc. Recent Developments
9.4 Boston Scientific
9.4.1 Boston Scientific Transarterial Chemoembolization (TACE) Basic Information
9.4.2 Boston Scientific Transarterial Chemoembolization (TACE) Product Overview
9.4.3 Boston Scientific Transarterial Chemoembolization (TACE) Product Market Performance
9.4.4 Boston Scientific Business Overview
9.4.5 Boston Scientific Recent Developments
9.5 Cook Group
9.5.1 Cook Group Transarterial Chemoembolization (TACE) Basic Information
9.5.2 Cook Group Transarterial Chemoembolization (TACE) Product Overview
9.5.3 Cook Group Transarterial Chemoembolization (TACE) Product Market Performance
9.5.4 Cook Group Business Overview
9.5.5 Cook Group Recent Developments
9.6 Hikma Pharmaceuticals
9.6.1 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Basic Information
9.6.2 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Overview
9.6.3 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Market Performance
9.6.4 Hikma Pharmaceuticals Business Overview
9.6.5 Hikma Pharmaceuticals Recent Developments
9.7 Nippon Kayaku
9.7.1 Nippon Kayaku Transarterial Chemoembolization (TACE) Basic Information
9.7.2 Nippon Kayaku Transarterial Chemoembolization (TACE) Product Overview
9.7.3 Nippon Kayaku Transarterial Chemoembolization (TACE) Product Market Performance
9.7.4 Nippon Kayaku Business Overview
9.7.5 Nippon Kayaku Recent Developments
9.8 Novartis AG
9.8.1 Novartis AG Transarterial Chemoembolization (TACE) Basic Information
9.8.2 Novartis AG Transarterial Chemoembolization (TACE) Product Overview
9.8.3 Novartis AG Transarterial Chemoembolization (TACE) Product Market Performance
9.8.4 Novartis AG Business Overview
9.8.5 Novartis AG Recent Developments
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Transarterial Chemoembolization (TACE) Basic Information
9.9.2 Pfizer Inc. Transarterial Chemoembolization (TACE) Product Overview
9.9.3 Pfizer Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.9.4 Pfizer Inc. Business Overview
9.9.5 Pfizer Inc. Recent Developments
9.10 Spectrum Pharmaceutical
9.10.1 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Basic Information
9.10.2 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Overview
9.10.3 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Market Performance
9.10.4 Spectrum Pharmaceutical Business Overview
9.10.5 Spectrum Pharmaceutical Recent Developments
9.11 Roche Holding AG
9.11.1 Roche Holding AG Transarterial Chemoembolization (TACE) Basic Information
9.11.2 Roche Holding AG Transarterial Chemoembolization (TACE) Product Overview
9.11.3 Roche Holding AG Transarterial Chemoembolization (TACE) Product Market Performance
9.11.4 Roche Holding AG Business Overview
9.11.5 Roche Holding AG Recent Developments
9.12 Celgene
9.12.1 Celgene Transarterial Chemoembolization (TACE) Basic Information
9.12.2 Celgene Transarterial Chemoembolization (TACE) Product Overview
9.12.3 Celgene Transarterial Chemoembolization (TACE) Product Market Performance
9.12.4 Celgene Business Overview
9.12.5 Celgene Recent Developments
9.13 Bayer AG
9.13.1 Bayer AG Transarterial Chemoembolization (TACE) Basic Information
9.13.2 Bayer AG Transarterial Chemoembolization (TACE) Product Overview
9.13.3 Bayer AG Transarterial Chemoembolization (TACE) Product Market Performance
9.13.4 Bayer AG Business Overview
9.13.5 Bayer AG Recent Developments
9.14 Merck and Co.
9.14.1 Merck and Co. Transarterial Chemoembolization (TACE) Basic Information
9.14.2 Merck and Co. Transarterial Chemoembolization (TACE) Product Overview
9.14.3 Merck and Co. Transarterial Chemoembolization (TACE) Product Market Performance
9.14.4 Merck and Co. Business Overview
9.14.5 Merck and Co. Recent Developments
9.15 Inc.
9.15.1 Inc. Transarterial Chemoembolization (TACE) Basic Information
9.15.2 Inc. Transarterial Chemoembolization (TACE) Product Overview
9.15.3 Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.15.4 Inc. Business Overview
9.15.5 Inc. Recent Developments
9.16 SingHealth
9.16.1 SingHealth Transarterial Chemoembolization (TACE) Basic Information
9.16.2 SingHealth Transarterial Chemoembolization (TACE) Product Overview
9.16.3 SingHealth Transarterial Chemoembolization (TACE) Product Market Performance
9.16.4 SingHealth Business Overview
9.16.5 SingHealth Recent Developments
10 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET FORECAST BY REGION
10.1 Global Transarterial Chemoembolization (TACE) Market Size Forecast
10.2 Global Transarterial Chemoembolization (TACE) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transarterial Chemoembolization (TACE) Market Size Forecast by Country
10.2.3 Asia Pacific Transarterial Chemoembolization (TACE) Market Size Forecast by Region
10.2.4 South America Transarterial Chemoembolization (TACE) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transarterial Chemoembolization (TACE) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Transarterial Chemoembolization (TACE) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Transarterial Chemoembolization (TACE) by Type (2025-2030)
11.1.2 Global Transarterial Chemoembolization (TACE) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Transarterial Chemoembolization (TACE) by Type (2025-2030)
11.2 Global Transarterial Chemoembolization (TACE) Market Forecast by Application (2025-2030)
11.2.1 Global Transarterial Chemoembolization (TACE) Sales (K Units) Forecast by Application
11.2.2 Global Transarterial Chemoembolization (TACE) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Transarterial Chemoembolization (TACE)
1.2 Key Market Segments
1.2.1 Transarterial Chemoembolization (TACE) Segment by Type
1.2.2 Transarterial Chemoembolization (TACE) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Transarterial Chemoembolization (TACE) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Transarterial Chemoembolization (TACE) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET COMPETITIVE LANDSCAPE
3.1 Global Transarterial Chemoembolization (TACE) Sales by Manufacturers (2019-2024)
3.2 Global Transarterial Chemoembolization (TACE) Revenue Market Share by Manufacturers (2019-2024)
3.3 Transarterial Chemoembolization (TACE) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transarterial Chemoembolization (TACE) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Transarterial Chemoembolization (TACE) Sales Sites, Area Served, Product Type
3.6 Transarterial Chemoembolization (TACE) Market Competitive Situation and Trends
3.6.1 Transarterial Chemoembolization (TACE) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transarterial Chemoembolization (TACE) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) INDUSTRY CHAIN ANALYSIS
4.1 Transarterial Chemoembolization (TACE) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transarterial Chemoembolization (TACE) Sales Market Share by Type (2019-2024)
6.3 Global Transarterial Chemoembolization (TACE) Market Size Market Share by Type (2019-2024)
6.4 Global Transarterial Chemoembolization (TACE) Price by Type (2019-2024)
7 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transarterial Chemoembolization (TACE) Market Sales by Application (2019-2024)
7.3 Global Transarterial Chemoembolization (TACE) Market Size (M USD) by Application (2019-2024)
7.4 Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
8 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET SEGMENTATION BY REGION
8.1 Global Transarterial Chemoembolization (TACE) Sales by Region
8.1.1 Global Transarterial Chemoembolization (TACE) Sales by Region
8.1.2 Global Transarterial Chemoembolization (TACE) Sales Market Share by Region
8.2 North America
8.2.1 North America Transarterial Chemoembolization (TACE) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transarterial Chemoembolization (TACE) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transarterial Chemoembolization (TACE) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transarterial Chemoembolization (TACE) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transarterial Chemoembolization (TACE) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Questex
9.1.1 Questex Transarterial Chemoembolization (TACE) Basic Information
9.1.2 Questex Transarterial Chemoembolization (TACE) Product Overview
9.1.3 Questex Transarterial Chemoembolization (TACE) Product Market Performance
9.1.4 Questex Business Overview
9.1.5 Questex Transarterial Chemoembolization (TACE) SWOT Analysis
9.1.6 Questex Recent Developments
9.2 Siemens Healthcare GmbH
9.2.1 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Basic Information
9.2.2 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Overview
9.2.3 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Market Performance
9.2.4 Siemens Healthcare GmbH Business Overview
9.2.5 Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) SWOT Analysis
9.2.6 Siemens Healthcare GmbH Recent Developments
9.3 Bellicum Pharmaceuticals Inc.
9.3.1 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Basic Information
9.3.2 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Overview
9.3.3 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.3.4 Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) SWOT Analysis
9.3.5 Bellicum Pharmaceuticals Inc. Business Overview
9.3.6 Bellicum Pharmaceuticals Inc. Recent Developments
9.4 Boston Scientific
9.4.1 Boston Scientific Transarterial Chemoembolization (TACE) Basic Information
9.4.2 Boston Scientific Transarterial Chemoembolization (TACE) Product Overview
9.4.3 Boston Scientific Transarterial Chemoembolization (TACE) Product Market Performance
9.4.4 Boston Scientific Business Overview
9.4.5 Boston Scientific Recent Developments
9.5 Cook Group
9.5.1 Cook Group Transarterial Chemoembolization (TACE) Basic Information
9.5.2 Cook Group Transarterial Chemoembolization (TACE) Product Overview
9.5.3 Cook Group Transarterial Chemoembolization (TACE) Product Market Performance
9.5.4 Cook Group Business Overview
9.5.5 Cook Group Recent Developments
9.6 Hikma Pharmaceuticals
9.6.1 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Basic Information
9.6.2 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Overview
9.6.3 Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Market Performance
9.6.4 Hikma Pharmaceuticals Business Overview
9.6.5 Hikma Pharmaceuticals Recent Developments
9.7 Nippon Kayaku
9.7.1 Nippon Kayaku Transarterial Chemoembolization (TACE) Basic Information
9.7.2 Nippon Kayaku Transarterial Chemoembolization (TACE) Product Overview
9.7.3 Nippon Kayaku Transarterial Chemoembolization (TACE) Product Market Performance
9.7.4 Nippon Kayaku Business Overview
9.7.5 Nippon Kayaku Recent Developments
9.8 Novartis AG
9.8.1 Novartis AG Transarterial Chemoembolization (TACE) Basic Information
9.8.2 Novartis AG Transarterial Chemoembolization (TACE) Product Overview
9.8.3 Novartis AG Transarterial Chemoembolization (TACE) Product Market Performance
9.8.4 Novartis AG Business Overview
9.8.5 Novartis AG Recent Developments
9.9 Pfizer Inc.
9.9.1 Pfizer Inc. Transarterial Chemoembolization (TACE) Basic Information
9.9.2 Pfizer Inc. Transarterial Chemoembolization (TACE) Product Overview
9.9.3 Pfizer Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.9.4 Pfizer Inc. Business Overview
9.9.5 Pfizer Inc. Recent Developments
9.10 Spectrum Pharmaceutical
9.10.1 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Basic Information
9.10.2 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Overview
9.10.3 Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Market Performance
9.10.4 Spectrum Pharmaceutical Business Overview
9.10.5 Spectrum Pharmaceutical Recent Developments
9.11 Roche Holding AG
9.11.1 Roche Holding AG Transarterial Chemoembolization (TACE) Basic Information
9.11.2 Roche Holding AG Transarterial Chemoembolization (TACE) Product Overview
9.11.3 Roche Holding AG Transarterial Chemoembolization (TACE) Product Market Performance
9.11.4 Roche Holding AG Business Overview
9.11.5 Roche Holding AG Recent Developments
9.12 Celgene
9.12.1 Celgene Transarterial Chemoembolization (TACE) Basic Information
9.12.2 Celgene Transarterial Chemoembolization (TACE) Product Overview
9.12.3 Celgene Transarterial Chemoembolization (TACE) Product Market Performance
9.12.4 Celgene Business Overview
9.12.5 Celgene Recent Developments
9.13 Bayer AG
9.13.1 Bayer AG Transarterial Chemoembolization (TACE) Basic Information
9.13.2 Bayer AG Transarterial Chemoembolization (TACE) Product Overview
9.13.3 Bayer AG Transarterial Chemoembolization (TACE) Product Market Performance
9.13.4 Bayer AG Business Overview
9.13.5 Bayer AG Recent Developments
9.14 Merck and Co.
9.14.1 Merck and Co. Transarterial Chemoembolization (TACE) Basic Information
9.14.2 Merck and Co. Transarterial Chemoembolization (TACE) Product Overview
9.14.3 Merck and Co. Transarterial Chemoembolization (TACE) Product Market Performance
9.14.4 Merck and Co. Business Overview
9.14.5 Merck and Co. Recent Developments
9.15 Inc.
9.15.1 Inc. Transarterial Chemoembolization (TACE) Basic Information
9.15.2 Inc. Transarterial Chemoembolization (TACE) Product Overview
9.15.3 Inc. Transarterial Chemoembolization (TACE) Product Market Performance
9.15.4 Inc. Business Overview
9.15.5 Inc. Recent Developments
9.16 SingHealth
9.16.1 SingHealth Transarterial Chemoembolization (TACE) Basic Information
9.16.2 SingHealth Transarterial Chemoembolization (TACE) Product Overview
9.16.3 SingHealth Transarterial Chemoembolization (TACE) Product Market Performance
9.16.4 SingHealth Business Overview
9.16.5 SingHealth Recent Developments
10 TRANSARTERIAL CHEMOEMBOLIZATION (TACE) MARKET FORECAST BY REGION
10.1 Global Transarterial Chemoembolization (TACE) Market Size Forecast
10.2 Global Transarterial Chemoembolization (TACE) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transarterial Chemoembolization (TACE) Market Size Forecast by Country
10.2.3 Asia Pacific Transarterial Chemoembolization (TACE) Market Size Forecast by Region
10.2.4 South America Transarterial Chemoembolization (TACE) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transarterial Chemoembolization (TACE) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Transarterial Chemoembolization (TACE) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Transarterial Chemoembolization (TACE) by Type (2025-2030)
11.1.2 Global Transarterial Chemoembolization (TACE) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Transarterial Chemoembolization (TACE) by Type (2025-2030)
11.2 Global Transarterial Chemoembolization (TACE) Market Forecast by Application (2025-2030)
11.2.1 Global Transarterial Chemoembolization (TACE) Sales (K Units) Forecast by Application
11.2.2 Global Transarterial Chemoembolization (TACE) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Transarterial Chemoembolization (TACE) Market Size Comparison by Region (M USD)
Table 5. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Transarterial Chemoembolization (TACE) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Transarterial Chemoembolization (TACE) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Transarterial Chemoembolization (TACE) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Chemoembolization (TACE) as of 2022)
Table 10. Global Market Transarterial Chemoembolization (TACE) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Transarterial Chemoembolization (TACE) Sales Sites and Area Served
Table 12. Manufacturers Transarterial Chemoembolization (TACE) Product Type
Table 13. Global Transarterial Chemoembolization (TACE) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Transarterial Chemoembolization (TACE)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Transarterial Chemoembolization (TACE) Market Challenges
Table 22. Global Transarterial Chemoembolization (TACE) Sales by Type (K Units)
Table 23. Global Transarterial Chemoembolization (TACE) Market Size by Type (M USD)
Table 24. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Type (2019-2024)
Table 25. Global Transarterial Chemoembolization (TACE) Sales Market Share by Type (2019-2024)
Table 26. Global Transarterial Chemoembolization (TACE) Market Size (M USD) by Type (2019-2024)
Table 27. Global Transarterial Chemoembolization (TACE) Market Size Share by Type (2019-2024)
Table 28. Global Transarterial Chemoembolization (TACE) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Application
Table 30. Global Transarterial Chemoembolization (TACE) Market Size by Application
Table 31. Global Transarterial Chemoembolization (TACE) Sales by Application (2019-2024) & (K Units)
Table 32. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application (2019-2024)
Table 33. Global Transarterial Chemoembolization (TACE) Sales by Application (2019-2024) & (M USD)
Table 34. Global Transarterial Chemoembolization (TACE) Market Share by Application (2019-2024)
Table 35. Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
Table 36. Global Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 37. Global Transarterial Chemoembolization (TACE) Sales Market Share by Region (2019-2024)
Table 38. North America Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 41. South America Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 43. Questex Transarterial Chemoembolization (TACE) Basic Information
Table 44. Questex Transarterial Chemoembolization (TACE) Product Overview
Table 45. Questex Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Questex Business Overview
Table 47. Questex Transarterial Chemoembolization (TACE) SWOT Analysis
Table 48. Questex Recent Developments
Table 49. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Basic Information
Table 50. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Overview
Table 51. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Siemens Healthcare GmbH Business Overview
Table 53. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) SWOT Analysis
Table 54. Siemens Healthcare GmbH Recent Developments
Table 55. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 56. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 57. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) SWOT Analysis
Table 59. Bellicum Pharmaceuticals Inc. Business Overview
Table 60. Bellicum Pharmaceuticals Inc. Recent Developments
Table 61. Boston Scientific Transarterial Chemoembolization (TACE) Basic Information
Table 62. Boston Scientific Transarterial Chemoembolization (TACE) Product Overview
Table 63. Boston Scientific Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Boston Scientific Business Overview
Table 65. Boston Scientific Recent Developments
Table 66. Cook Group Transarterial Chemoembolization (TACE) Basic Information
Table 67. Cook Group Transarterial Chemoembolization (TACE) Product Overview
Table 68. Cook Group Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cook Group Business Overview
Table 70. Cook Group Recent Developments
Table 71. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Basic Information
Table 72. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Overview
Table 73. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Hikma Pharmaceuticals Business Overview
Table 75. Hikma Pharmaceuticals Recent Developments
Table 76. Nippon Kayaku Transarterial Chemoembolization (TACE) Basic Information
Table 77. Nippon Kayaku Transarterial Chemoembolization (TACE) Product Overview
Table 78. Nippon Kayaku Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Nippon Kayaku Business Overview
Table 80. Nippon Kayaku Recent Developments
Table 81. Novartis AG Transarterial Chemoembolization (TACE) Basic Information
Table 82. Novartis AG Transarterial Chemoembolization (TACE) Product Overview
Table 83. Novartis AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Recent Developments
Table 86. Pfizer Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 87. Pfizer Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 88. Pfizer Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Recent Developments
Table 91. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Basic Information
Table 92. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Overview
Table 93. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Spectrum Pharmaceutical Business Overview
Table 95. Spectrum Pharmaceutical Recent Developments
Table 96. Roche Holding AG Transarterial Chemoembolization (TACE) Basic Information
Table 97. Roche Holding AG Transarterial Chemoembolization (TACE) Product Overview
Table 98. Roche Holding AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Recent Developments
Table 101. Celgene Transarterial Chemoembolization (TACE) Basic Information
Table 102. Celgene Transarterial Chemoembolization (TACE) Product Overview
Table 103. Celgene Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Celgene Business Overview
Table 105. Celgene Recent Developments
Table 106. Bayer AG Transarterial Chemoembolization (TACE) Basic Information
Table 107. Bayer AG Transarterial Chemoembolization (TACE) Product Overview
Table 108. Bayer AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Bayer AG Business Overview
Table 110. Bayer AG Recent Developments
Table 111. Merck and Co. Transarterial Chemoembolization (TACE) Basic Information
Table 112. Merck and Co. Transarterial Chemoembolization (TACE) Product Overview
Table 113. Merck and Co. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Merck and Co. Business Overview
Table 115. Merck and Co. Recent Developments
Table 116. Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 117. Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 118. Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Inc. Business Overview
Table 120. Inc. Recent Developments
Table 121. SingHealth Transarterial Chemoembolization (TACE) Basic Information
Table 122. SingHealth Transarterial Chemoembolization (TACE) Product Overview
Table 123. SingHealth Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. SingHealth Business Overview
Table 125. SingHealth Recent Developments
Table 126. Global Transarterial Chemoembolization (TACE) Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Transarterial Chemoembolization (TACE) Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Transarterial Chemoembolization (TACE) Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Transarterial Chemoembolization (TACE) Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Transarterial Chemoembolization (TACE) Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Transarterial Chemoembolization (TACE) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Transarterial Chemoembolization (TACE) Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Transarterial Chemoembolization (TACE) Market Size Comparison by Region (M USD)
Table 5. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Transarterial Chemoembolization (TACE) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Transarterial Chemoembolization (TACE) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Transarterial Chemoembolization (TACE) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transarterial Chemoembolization (TACE) as of 2022)
Table 10. Global Market Transarterial Chemoembolization (TACE) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Transarterial Chemoembolization (TACE) Sales Sites and Area Served
Table 12. Manufacturers Transarterial Chemoembolization (TACE) Product Type
Table 13. Global Transarterial Chemoembolization (TACE) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Transarterial Chemoembolization (TACE)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Transarterial Chemoembolization (TACE) Market Challenges
Table 22. Global Transarterial Chemoembolization (TACE) Sales by Type (K Units)
Table 23. Global Transarterial Chemoembolization (TACE) Market Size by Type (M USD)
Table 24. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Type (2019-2024)
Table 25. Global Transarterial Chemoembolization (TACE) Sales Market Share by Type (2019-2024)
Table 26. Global Transarterial Chemoembolization (TACE) Market Size (M USD) by Type (2019-2024)
Table 27. Global Transarterial Chemoembolization (TACE) Market Size Share by Type (2019-2024)
Table 28. Global Transarterial Chemoembolization (TACE) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Transarterial Chemoembolization (TACE) Sales (K Units) by Application
Table 30. Global Transarterial Chemoembolization (TACE) Market Size by Application
Table 31. Global Transarterial Chemoembolization (TACE) Sales by Application (2019-2024) & (K Units)
Table 32. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application (2019-2024)
Table 33. Global Transarterial Chemoembolization (TACE) Sales by Application (2019-2024) & (M USD)
Table 34. Global Transarterial Chemoembolization (TACE) Market Share by Application (2019-2024)
Table 35. Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
Table 36. Global Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 37. Global Transarterial Chemoembolization (TACE) Sales Market Share by Region (2019-2024)
Table 38. North America Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 41. South America Transarterial Chemoembolization (TACE) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Transarterial Chemoembolization (TACE) Sales by Region (2019-2024) & (K Units)
Table 43. Questex Transarterial Chemoembolization (TACE) Basic Information
Table 44. Questex Transarterial Chemoembolization (TACE) Product Overview
Table 45. Questex Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Questex Business Overview
Table 47. Questex Transarterial Chemoembolization (TACE) SWOT Analysis
Table 48. Questex Recent Developments
Table 49. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Basic Information
Table 50. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Product Overview
Table 51. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Siemens Healthcare GmbH Business Overview
Table 53. Siemens Healthcare GmbH Transarterial Chemoembolization (TACE) SWOT Analysis
Table 54. Siemens Healthcare GmbH Recent Developments
Table 55. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 56. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 57. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bellicum Pharmaceuticals Inc. Transarterial Chemoembolization (TACE) SWOT Analysis
Table 59. Bellicum Pharmaceuticals Inc. Business Overview
Table 60. Bellicum Pharmaceuticals Inc. Recent Developments
Table 61. Boston Scientific Transarterial Chemoembolization (TACE) Basic Information
Table 62. Boston Scientific Transarterial Chemoembolization (TACE) Product Overview
Table 63. Boston Scientific Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Boston Scientific Business Overview
Table 65. Boston Scientific Recent Developments
Table 66. Cook Group Transarterial Chemoembolization (TACE) Basic Information
Table 67. Cook Group Transarterial Chemoembolization (TACE) Product Overview
Table 68. Cook Group Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cook Group Business Overview
Table 70. Cook Group Recent Developments
Table 71. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Basic Information
Table 72. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Product Overview
Table 73. Hikma Pharmaceuticals Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Hikma Pharmaceuticals Business Overview
Table 75. Hikma Pharmaceuticals Recent Developments
Table 76. Nippon Kayaku Transarterial Chemoembolization (TACE) Basic Information
Table 77. Nippon Kayaku Transarterial Chemoembolization (TACE) Product Overview
Table 78. Nippon Kayaku Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Nippon Kayaku Business Overview
Table 80. Nippon Kayaku Recent Developments
Table 81. Novartis AG Transarterial Chemoembolization (TACE) Basic Information
Table 82. Novartis AG Transarterial Chemoembolization (TACE) Product Overview
Table 83. Novartis AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Novartis AG Business Overview
Table 85. Novartis AG Recent Developments
Table 86. Pfizer Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 87. Pfizer Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 88. Pfizer Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Pfizer Inc. Business Overview
Table 90. Pfizer Inc. Recent Developments
Table 91. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Basic Information
Table 92. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Product Overview
Table 93. Spectrum Pharmaceutical Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Spectrum Pharmaceutical Business Overview
Table 95. Spectrum Pharmaceutical Recent Developments
Table 96. Roche Holding AG Transarterial Chemoembolization (TACE) Basic Information
Table 97. Roche Holding AG Transarterial Chemoembolization (TACE) Product Overview
Table 98. Roche Holding AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holding AG Business Overview
Table 100. Roche Holding AG Recent Developments
Table 101. Celgene Transarterial Chemoembolization (TACE) Basic Information
Table 102. Celgene Transarterial Chemoembolization (TACE) Product Overview
Table 103. Celgene Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Celgene Business Overview
Table 105. Celgene Recent Developments
Table 106. Bayer AG Transarterial Chemoembolization (TACE) Basic Information
Table 107. Bayer AG Transarterial Chemoembolization (TACE) Product Overview
Table 108. Bayer AG Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Bayer AG Business Overview
Table 110. Bayer AG Recent Developments
Table 111. Merck and Co. Transarterial Chemoembolization (TACE) Basic Information
Table 112. Merck and Co. Transarterial Chemoembolization (TACE) Product Overview
Table 113. Merck and Co. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Merck and Co. Business Overview
Table 115. Merck and Co. Recent Developments
Table 116. Inc. Transarterial Chemoembolization (TACE) Basic Information
Table 117. Inc. Transarterial Chemoembolization (TACE) Product Overview
Table 118. Inc. Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Inc. Business Overview
Table 120. Inc. Recent Developments
Table 121. SingHealth Transarterial Chemoembolization (TACE) Basic Information
Table 122. SingHealth Transarterial Chemoembolization (TACE) Product Overview
Table 123. SingHealth Transarterial Chemoembolization (TACE) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. SingHealth Business Overview
Table 125. SingHealth Recent Developments
Table 126. Global Transarterial Chemoembolization (TACE) Sales Forecast by Region (2025-2030) & (K Units)
Table 127. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 129. North America Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 131. Europe Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Transarterial Chemoembolization (TACE) Sales Forecast by Region (2025-2030) & (K Units)
Table 133. Asia Pacific Transarterial Chemoembolization (TACE) Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Transarterial Chemoembolization (TACE) Sales Forecast by Country (2025-2030) & (K Units)
Table 135. South America Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Transarterial Chemoembolization (TACE) Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Transarterial Chemoembolization (TACE) Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Transarterial Chemoembolization (TACE) Sales Forecast by Type (2025-2030) & (K Units)
Table 139. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Transarterial Chemoembolization (TACE) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 141. Global Transarterial Chemoembolization (TACE) Sales (K Units) Forecast by Application (2025-2030)
Table 142. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Transarterial Chemoembolization (TACE)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Transarterial Chemoembolization (TACE) Market Size (M USD), 2019-2030
Figure 5. Global Transarterial Chemoembolization (TACE) Market Size (M USD) (2019-2030)
Figure 6. Global Transarterial Chemoembolization (TACE) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Transarterial Chemoembolization (TACE) Market Size by Country (M USD)
Figure 11. Transarterial Chemoembolization (TACE) Sales Share by Manufacturers in 2023
Figure 12. Global Transarterial Chemoembolization (TACE) Revenue Share by Manufacturers in 2023
Figure 13. Transarterial Chemoembolization (TACE) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Transarterial Chemoembolization (TACE) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Transarterial Chemoembolization (TACE) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Transarterial Chemoembolization (TACE) Market Share by Type
Figure 18. Sales Market Share of Transarterial Chemoembolization (TACE) by Type (2019-2024)
Figure 19. Sales Market Share of Transarterial Chemoembolization (TACE) by Type in 2023
Figure 20. Market Size Share of Transarterial Chemoembolization (TACE) by Type (2019-2024)
Figure 21. Market Size Market Share of Transarterial Chemoembolization (TACE) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Transarterial Chemoembolization (TACE) Market Share by Application
Figure 24. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application (2019-2024)
Figure 25. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application in 2023
Figure 26. Global Transarterial Chemoembolization (TACE) Market Share by Application (2019-2024)
Figure 27. Global Transarterial Chemoembolization (TACE) Market Share by Application in 2023
Figure 28. Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Transarterial Chemoembolization (TACE) Sales Market Share by Region (2019-2024)
Figure 30. North America Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 32. U.S. Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Transarterial Chemoembolization (TACE) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Transarterial Chemoembolization (TACE) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 37. Germany Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Transarterial Chemoembolization (TACE) Sales Market Share by Region in 2023
Figure 44. China Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 50. South America Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 51. Brazil Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Transarterial Chemoembolization (TACE) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Transarterial Chemoembolization (TACE) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Transarterial Chemoembolization (TACE) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Transarterial Chemoembolization (TACE) Market Share Forecast by Type (2025-2030)
Figure 65. Global Transarterial Chemoembolization (TACE) Sales Forecast by Application (2025-2030)
Figure 66. Global Transarterial Chemoembolization (TACE) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Transarterial Chemoembolization (TACE)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Transarterial Chemoembolization (TACE) Market Size (M USD), 2019-2030
Figure 5. Global Transarterial Chemoembolization (TACE) Market Size (M USD) (2019-2030)
Figure 6. Global Transarterial Chemoembolization (TACE) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Transarterial Chemoembolization (TACE) Market Size by Country (M USD)
Figure 11. Transarterial Chemoembolization (TACE) Sales Share by Manufacturers in 2023
Figure 12. Global Transarterial Chemoembolization (TACE) Revenue Share by Manufacturers in 2023
Figure 13. Transarterial Chemoembolization (TACE) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Transarterial Chemoembolization (TACE) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Transarterial Chemoembolization (TACE) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Transarterial Chemoembolization (TACE) Market Share by Type
Figure 18. Sales Market Share of Transarterial Chemoembolization (TACE) by Type (2019-2024)
Figure 19. Sales Market Share of Transarterial Chemoembolization (TACE) by Type in 2023
Figure 20. Market Size Share of Transarterial Chemoembolization (TACE) by Type (2019-2024)
Figure 21. Market Size Market Share of Transarterial Chemoembolization (TACE) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Transarterial Chemoembolization (TACE) Market Share by Application
Figure 24. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application (2019-2024)
Figure 25. Global Transarterial Chemoembolization (TACE) Sales Market Share by Application in 2023
Figure 26. Global Transarterial Chemoembolization (TACE) Market Share by Application (2019-2024)
Figure 27. Global Transarterial Chemoembolization (TACE) Market Share by Application in 2023
Figure 28. Global Transarterial Chemoembolization (TACE) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Transarterial Chemoembolization (TACE) Sales Market Share by Region (2019-2024)
Figure 30. North America Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 32. U.S. Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Transarterial Chemoembolization (TACE) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Transarterial Chemoembolization (TACE) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 37. Germany Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Transarterial Chemoembolization (TACE) Sales Market Share by Region in 2023
Figure 44. China Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 50. South America Transarterial Chemoembolization (TACE) Sales Market Share by Country in 2023
Figure 51. Brazil Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Transarterial Chemoembolization (TACE) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Transarterial Chemoembolization (TACE) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Transarterial Chemoembolization (TACE) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Transarterial Chemoembolization (TACE) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Transarterial Chemoembolization (TACE) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Transarterial Chemoembolization (TACE) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Transarterial Chemoembolization (TACE) Market Share Forecast by Type (2025-2030)
Figure 65. Global Transarterial Chemoembolization (TACE) Sales Forecast by Application (2025-2030)
Figure 66. Global Transarterial Chemoembolization (TACE) Market Share Forecast by Application (2025-2030)
